These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1873811)

  • 1. Characterization of multidrug resistance by fluorescent dyes.
    Kessel D; Beck WT; Kukuruga D; Schulz V
    Cancer Res; 1991 Sep; 51(17):4665-70. PubMed ID: 1873811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring multidrug resistance using rhodamine 123.
    Kessel D
    Cancer Commun; 1989; 1(3):145-9. PubMed ID: 2639727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of human leukemia cells with multidrug-resistance phenotype using multilabeling with fluorescent dyes.
    Lautier D; Lahmy S; Canitrot Y; Vigo J; Viallet P; Salmon JM
    Anticancer Res; 1993; 13(5A):1557-63. PubMed ID: 8239535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
    Ganapathi R; Reiter W; Krishan A
    J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
    Kessel D; Wilberding C
    Cancer Res; 1985 Apr; 45(4):1687-91. PubMed ID: 3919944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline.
    Ramu N; Ramu A; Cole DE; Balis FM; Poplack DG; Pollard HB
    Isr J Med Sci; 1988; 24(9-10):477-82. PubMed ID: 2974448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance of murine leukemia cells characterization and correlation with cytochrome P-450 dependent activities, cytosolic calcium and cell cycle state.
    Pfeil D; Bergmann J; Fichtner I; Stein U; Hentschel M; Rothe I; Goan SR
    Anticancer Res; 1994; 14(2A):571-6. PubMed ID: 7912495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Goldenberg GJ; Wang H; Blair GW
    Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of subcellular distribution of doxorubicin in multidrug-resistant P388/ADR mouse leukemia cells by the chemosensitizer ((2-isopropyl-1-(4-[3-N-methyl-N-(3,4-dimethoxy-beta- phenethyl)amino]propyloxy)-benzenesulfonyl))indolizine.
    Jaffrézou JP; Levade T; Chatelain P; Laurent G
    Cancer Res; 1992 Dec; 52(23):6440-6. PubMed ID: 1423291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of highly multidrug-resistant P388 cells from drug-sensitive P388/S cells by flow cytometric cell sorting.
    Ross DD; Ordóñez JV; Joneckis CC; Testa JR; Thompson BW
    Cytometry; 1988 Jul; 9(4):359-67. PubMed ID: 3402281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion of daunorubicin uptake and toxicity by the calcium antagonist tiapamil and its analogs.
    Kessel D; Wilberding C
    Cancer Treat Rep; 1985 Jun; 69(6):673-6. PubMed ID: 4016770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo development and in vitro characterization of a subclone of murine P388 leukemia resistant to bis(diphenylphosphine)ethane.
    Hoke GD; McCabe FL; Faucette LF; Bartus JO; Sung CM; Jensen BD; Heys JR; Rush GF; Alberts DW; Johnson RK
    Mol Pharmacol; 1991 Jan; 39(1):90-7. PubMed ID: 1898982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyes providing increased sensitivity in flow-cytometric dye-efflux assays for multidrug resistance.
    Frey T; Yue S; Haugland RP
    Cytometry; 1995 Jul; 20(3):218-27. PubMed ID: 7587707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
    Beck WT; Cirtain MC; Danks MK; Felsted RL; Safa AR; Wolverton JS; Suttle DP; Trent JM
    Cancer Res; 1987 Oct; 47(20):5455-60. PubMed ID: 2888532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
    Ramu A; Fuks Z; Gatt S; Glaubiger D
    Cancer Res; 1984 Jan; 44(1):144-8. PubMed ID: 6690032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in lipid composition of doxorubicin-sensitive and -resistant P388 cells.
    Ramu A; Glaubiger D; Weintraub H
    Cancer Treat Rep; 1984 Apr; 68(4):637-41. PubMed ID: 6713419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy of a phenothiazine and a bisquinaldinium calmodulin antagonist against multidrug-resistant P388 cell lines.
    Hait WN; Pierson NR
    Cancer Res; 1990 Feb; 50(4):1165-9. PubMed ID: 2297765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of microenvironmental pH on adriamycin resistance.
    Alabaster O; Woods T; Ortiz-Sanchez V; Jahangeer S
    Cancer Res; 1989 Oct; 49(20):5638-43. PubMed ID: 2790781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
    Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein.
    Bosch I; Dunussi-Joannopoulos K; Wu RL; Furlong ST; Croop J
    Biochemistry; 1997 May; 36(19):5685-94. PubMed ID: 9153408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.